Can you use Oncotype for determining adjuvant therapy in a young, premenopausal woman with multifocal HR+ breast cancer s/p mastectomy with 2 positive lymph nodes?
Answer from: Medical Oncologist at Academic Institution
There are no data yet that I am aware of (retrospective or prospective) for the use of Oncotype 21 gene assay to make treatment decisions in premenopausal women with node positive, estrogen receptor positive early stage breast cancer. The prospective RxPONDER trial will hopefully provide data on the...
Comments
Medical Oncologist at Winship Cancer Institute and Emory University School of Medicine I would exercise caution in utilizing the Recurren...
I would exercise caution in utilizing the Recurren...